Report

life science analytics market

Life Science Analytics Market by Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics), Application (Research & Development, Clinical Trials, Sales & Marketing, Supply Chain Optimization, and Pharmacovigilance), Component (Services and Software), End-User (Pharmaceutical & BioComponent Companies, Medical Device Companies, Research Centres and Third-party Administrators), Delivery Model (On-premise model and On-demand model) and Geography – Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026

pages Pages: 88
tables Tables: 87
charts Charts: 47
country Regions/Countries: 4/9
compaines Companies: 12
enqhours Enquiry Hours: 10
  • Get Free 10% Customization in this Report

COVID - 19

Covid impact updated reports at special price

Life science involves the study of living organisms. This study of life science includes all branches of science, such as zoology, botany, biology, and other sciences. Life science is the study that provides a significant perception of the different disease procedures and enables them to discover the therapies and medical equipment. Life science analytics is the software used to take advantage of the study to bring growth in global collaboration based on the grounds of accurate clinical information. The rise in the life science analytics market growth can be ascribed to factors such as the increasing volume of data in the life science industry, requirement of data normalization, and the rising burden of cutting healthcare expenses. But, data security issues may hinder the market growth. Life Science Analytics Market is predicted to grow at a CAGR of 10.80% with a market value of $42.23 billion in 2026.

Research Methodology:

The life science analytics market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

Life Science Analytics Market

Life Science Analytics market scope

Type: Market Size & Analysis

  • Descriptive Analytics         
  • Predictive Analytics           
  • Prescriptive Analytics

Application: Market Size & Analysis         

  • Research & Development
  • Clinical Trials          
  • Sales & Marketing
  • Supply Chain Optimization
  • Pharmacovigilance

Component: Market Size & Analysis

  • Services        
  • Software       

End-User: Market Size & Analysis

  • Pharmaceutical & BioComponent Companies 
  • Medical Device Companies           
  • Research Centres    
  • Third-party Administrators         

Delivery Model: Market Size & Analysis

  • On-premise model
  • On-demand model

Geography: Market Size & Analysis

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The life science analytics market is analyzed by the three types of analytics, such as descriptive analytics, predictive analytics, and prescriptive analytics. In these analytics, the mostly utilized analytics is descriptive analytics, as it is widely used by the life science stakeholders to get a better emphasis on the present scenario by comparing it with the previous events.

Further, the life science analytics market is further segmented into the application market. In the application market, the sales and marketing applications can be predicted to have the largest share in the market growth. This growth is due to the increasing deployment of life science analytics in the life science firm to conduct the sales and marketing promotion and also the growing preference of after marketing survey.

Moving on to the component segment in the life science analytics market is segregated into services and software. The service component has held the largest share due to the rising burden of reducing costs in healthcare and for the invention of advanced treatments in less time.

Life science analytics market based on end-user, the pharmaceutical and biocomponent companies, are the most life science analytics utilizing end-users because of the wide usage of the analytics in the sales and marketing by pharmaceutical company and usage of solutions gained by the analytics in biocomponent company.

Then the life science analytics market is segmented on the bases of the delivery model. The delivery model segment is divided into on-premise and on-demand. The on-demand delivery model has held the largest demand share due to the user-friendly feature of this delivery model.

Geographically, North America accounted for the largest share due to rapidly increasing diseases due to the increase in the geriatric population, potential economy, and growing expenditure on research and development are factors driving life science analytics the market growth. Moreover, the unhealthy lifestyle of people in this region is supporting market growth.

The global life science analytics the market is rapidly penetrating its position all over the world with its authentic features. The comprehensive analysis of the global driving insights of the market includes the globally increased advanced technology, evolution of social media & its effect on life science, and also the requirement of better outcomes of patients.   

SAS Institute Inc, IBM Corporation, Oracle Corporation, Iqvia, Accenture, Maxisit, Cognizant, Scio Health Analytics, Take Solutions, Wipro Limited, and 3DHISTECH, SAP SE. This is the list of few market competitors who are commanding the life science analytics the market.

Therefore, the life science analytics market is playing an important role in the healthcare sector by enhancing clinical trials and improving disease analysis. The life science analytics market study provides the market insights of drivers, challenges, and company strategies.

  • The life science analytics market study gives a substantial analysis of the market segmentation based on the various aspects.
  • This study presents an extensive analysis of geographical regions to ascertain the emerging opportunity from the entire world.
  • This study involves the complete quantitative analysis of the present market and estimations to recognize market opportunities.

      

1. Executive Summary

2. Industry Outlook

2.1. Industry Overview

2.2. Industry Trends

3. Market Snapshot

3.1. Market Definition

3.2. Market Outlook

3.3. PEST Analysis

3.4. Porter Five Forces

3.5. Related Markets

4. Market characteristics

4.1. Market Evolution

4.2. Market Trends and Impact

4.3. Advantages/Disadvantages of Market

4.4. Regulatory Impact

4.5. Market Offerings

4.6. Market Segmentation

4.7. Market Dynamics

4.7.1. Drivers

4.7.2. Restraints

4.7.3. Opportunities

4.8. DRO - Impact Analysis

5. Type: Market Size & Analysis

5.1. Overview

5.2. Descriptive Analytics            

5.3. Predictive Analytics              

5.4. Prescriptive Analytics

6. Application: Market Size & Analysis

6.1. Overview

6.2. Research & Development     

6.3. Clinical Trials

6.4. Sales & Marketing

6.5. Supply Chain Optimization

6.6. Pharmacovigilance

7. Component: Market Size & Analysis

7.1. Overview

7.2. Services      

7.3. Software     

8. End User: Market Size & Analysis

8.1. Overview

8.2. Pharmaceutical & BioComponent Companies

8.3. Medical Device Companies   

8.4. Research Centers     

8.5. Third-party Administrators   

9. Delivery Model: Market Size & Analysis

9.1. Overview

9.2. On-premise model

9.3. On-demand model

10. Geography: Market Size & Analysis

10.1. Overview

10.2. North America

10.3. Europe

10.4. Asia Pacific

10.5. Rest of the World

11. Competitive Landscape

11.1. Competitor Comparison Analysis

11.2. Market Developments

11.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships

11.2.2. Product Launches and execution

12. Vendor Profiles

12.1. SAS Institute Inc.

12.1.1. Overview

12.1.2. Product Offerings

12.1.3. Geographic Revenue

12.1.4. Business Units

12.1.5. Developments

12.1.6. Business Strategy

12.2. IBM Corporation

12.2.1. Overview

12.2.2. Product Offerings

12.2.3. Geographic Revenue

12.2.4. Business Units

12.2.5. Developments

12.2.6. Business Strategy

12.3. Oracle Corporation  

12.3.1. Overview

12.3.2. Product Offerings

12.3.3. Geographic Revenue

12.3.4. Business Units

12.3.5. Developments

12.3.6. Business Strategy

12.4. Iqvia

12.4.1. Overview

12.4.2. Product Offerings

12.4.3. Geographic Revenue

12.4.4. Business Units

12.4.5. Developments

12.4.6. Business Strategy

12.5. Accenture

12.5.1. Overview

12.5.2. Product Offerings

12.5.3. Geographic Revenue

12.5.4. Business Units

12.5.5. Developments

12.5.6. Business Strategy

12.6. Cognizant

12.6.1. Overview

12.6.2. Product Offerings

12.6.3. Geographic Revenue

12.6.4. Business Units

12.6.5. Developments

12.6.6. Business Strategy

12.7. Maxisit  

12.7.1. Overview

12.7.2. Product Offerings

12.7.3. Geographic Revenue

12.7.4. Business Units

12.7.5. Developments

12.7.6. Business Strategy

12.8. Scio Health Analytics

12.8.1. Overview

12.8.2. Product Offerings

12.8.3. Geographic Revenue

12.8.4. Business Units

12.8.5. Developments

12.8.6. Business Strategy

12.9. Take Solutions

12.9.1. Overview

12.9.2. Product Offerings

12.9.3. Geographic Revenue

12.9.4. Business Units

12.9.5. Developments

12.9.6. Business Strategy

12.10. Wipro Limited  

12.10.1. Overview

12.10.2. Product Offerings

12.10.3. Geographic Revenue

12.10.4. Business Units

12.10.5. Developments

12.10.6. Business Strategy

13. Companies to Watch

13.1. 3DHISTECH  

13.1.1. Overview

13.1.2. Market

13.1.3. Business Strategy

13.2. SAP SE. 

13.2.1. Overview

13.2.2. Market

13.2.3. Business Strategy

14. Analyst Opinion

15. Annexure

15.1. Report Scope

15.2. Market Definitions

15.3. Research Methodology

15.3.1. Data Collation and In-house Estimation

15.3.2. Market Triangulation

15.3.3. Forecasting

15.4. Report Assumptions

15.5. Declarations

15.6. Stakeholders

15.7. Abbreviations

TABLE 1.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 2.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PREDICTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRESCRIPTIVE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 5.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 6.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH & DEVELOPMENT, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PRECLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR CLINICAL TRIALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SALES & MARKETING, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR REGULATORY COMPLIANCE ANALYTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 11.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SUPPLY CHAIN OPTIMIZATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACOVIGILANCE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 14.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 17.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR PHARMACEUTICAL & BIOCOMPONENT COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 18.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR MEDICAL DEVICE COMPANIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 19.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR RESEARCH CENTERS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 20.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR THIRD-PARTY ADMINISTRATORS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 21.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR DELIVERY MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 22.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON PREMISE MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 23.    GLOBAL LIFE SCIENCE ANALYTICS MARKET VALUE FOR ON DEMAND MODEL, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 24.    NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 25.    NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 26.    NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 27.    NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 28.    NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 29.    NORTH AMERICA LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 30.    EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 31.    EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 32.    EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 33.    EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 34.    EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 35.    EUROPE LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 36.    ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 37.    ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 38.    ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 39.    ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 40.    ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 41.    ASIA PACIFIC LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 42.    REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 43.    REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY TYPE, 2020-2026 (USD BILLION)
TABLE 44.    REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 45.    REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY COMPONENT, 2020-2026 (USD BILLION)
TABLE 46.    REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY END USER, 2020-2026 (USD BILLION)
TABLE 47.    REST OF WORLD LIFE SCIENCE ANALYTICS MARKET VALUE, BY DELIVERY MODEL, 2020-2026 (USD BILLION)
TABLE 48.    SAS INSTITUTE INC.: OVERVIEW    
TABLE 49.    SAS INSTITUTE INC.: STRATEGIC SNAPSHOT    
TABLE 50.    SAS INSTITUTE INC.: BUSINESS FOCUS    
TABLE 51.    SAS INSTITUTE INC.: COMPONENT/SERVICE PORTFOLIO
TABLE 52.    IBM CORPORATION: OVERVIEW    
TABLE 53.    IBM CORPORATION: STRATEGIC SNAPSHOT    
TABLE 54.    IBM CORPORATION: BUSINESS FOCUS    
TABLE 55.    IBM CORPORATION: COMPONENT/SERVICE PORTFOLIO
TABLE 56.    ORACLE CORPORATION: OVERVIEW    
TABLE 57.    ORACLE CORPORATION: STRATEGIC SNAPSHOT    
TABLE 58.    ORACLE CORPORATION: BUSINESS FOCUS    
TABLE 59.    ORACLE CORPORATION: COMPONENT/SERVICE PORTFOLIO
TABLE 60.    IQVIA .: OVERVIEW    
TABLE 61.    IQVIA .: STRATEGIC SNAPSHOT    
TABLE 62.    IQVIA .: BUSINESS FOCUS    
TABLE 63.    IQVIA .: COMPONENT/SERVICE PORTFOLIO
TABLE 64.    ACCENTURE: OVERVIEW    
TABLE 65.    ACCENTURE: STRATEGIC SNAPSHOT    
TABLE 66.    ACCENTURE: BUSINESS FOCUS    
TABLE 67.    ACCENTURE: COMPONENT/SERVICE PORTFOLIO
TABLE 68.    CHOICESPINE: OVERVIEW    
TABLE 69.    CHOICESPINE: STRATEGIC SNAPSHOT    
TABLE 70.    CHOICESPINE: BUSINESS FOCUS    
TABLE 71.    CHOICESPINE: COMPONENT/SERVICE PORTFOLIO
TABLE 72.    MAXISIT: OVERVIEW    
TABLE 73.    MAXISIT: STRATEGIC SNAPSHOT    
TABLE 74.    MAXISIT: BUSINESS FOCUS    
TABLE 75.    MAXISIT: COMPONENT/SERVICE PORTFOLIO
TABLE 76.    SCIO HEALTH ANALYTICS: OVERVIEW    
TABLE 77.    SCIO HEALTH ANALYTICS: STRATEGIC SNAPSHOT    
TABLE 78.    SCIO HEALTH ANALYTICS: BUSINESS FOCUS    
TABLE 79.    SCIO HEALTH ANALYTICS: COMPONENT/SERVICE PORTFOLIO
TABLE 80.    TAKE SOLUTIONS: OVERVIEW    
TABLE 81.    TAKE SOLUTIONS: STRATEGIC SNAPSHOT    
TABLE 82.    TAKE SOLUTIONS: BUSINESS FOCUS    
TABLE 83.    TAKE SOLUTIONS: COMPONENT/SERVICE PORTFOLIO
TABLE 84.    WIPRO LIMITED: OVERVIEW    
TABLE 85.    WIPRO LIMITED: STRATEGIC SNAPSHOT    
TABLE 86.    WIPRO LIMITED: BUSINESS FOCUS    
TABLE 87.    WIPRO LIMITED: COMPONENT/SERVICE PORTFOLIO

Research Framework

Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting
Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources

Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

outicon

Life Science Analytics Market by Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics), Application (Research & Development, Clinical Trials, Sales & Marketing, Supply Chain Optimization, and Pharmacovigilance), Component (Services and Software), End-User (Pharmaceutical & BioComponent Companies, Medical Device Companies, Research Centres and Third-party Administrators), Delivery Model (On-premise model and On-demand model) and Geography – Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026
Interested in this report?
Get your FREE sample now!

Select User License

$

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Speak to our analyst
Related Reports